Literature DB >> 2153176

On the mechanism of non-allelically excluded V alpha-J alpha T cell receptor secondary rearrangements in a murine T cell lymphoma.

J D Fondell1, J P Marolleau, D Primi, K B Marcu.   

Abstract

We had previously demonstrated that several subclones derived from a CD3+, CD4-/CD8-, TCR-alpha beta+ murine T cell line have undergone secondary V alpha-J alpha rearrangements at the TCR-alpha locus (1). In an effort to examine the molecular mechanism responsible for these V alpha-J alpha replacements, the structures of TCR-alpha cDNA prepared from both the parental and subcloned T cell lines have been determined. Here we report that: 1) the mechanism whereby the secondary rearrangements occur is a precise deletion event that involves germ-line V alpha genes 5' to the preexisting V alpha-J alpha complex joining to J alpha segments 3' of the preexisting complex deleting the region in between, 2) preexisting productive V alpha-J alpha rearrangements of the parental line do not allelically exclude productive and nonproductive secondary rearrangements, 3) both productively rearranged TCR-alpha alleles of the parental cell line can undergo secondary rearrangements, 4) the presence of unrearranged germline V alpha transcripts in the parental line support an "accessibility" model of regulated lymphocyte receptor gene rearrangement. In addition, we present data which suggests that one of the subcloned lines has undergone a third rearrangement of one of its TCR-alpha alleles. One interpretation of these results is that T cells may have the ability to circumvent allelic exclusion at the TCR-alpha locus early in their ontogeny. This could provide T cells with an additional mechanism for generating an Ag receptor repertoire which is not found in B cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153176

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Transcription of germ line V alpha segments correlates with ongoing T-cell receptor alpha-chain rearrangement.

Authors:  J D Fondell; K B Marcu
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  A new mouse T-cell receptor alpha chain variable region family.

Authors:  R M Sutherland; Y Paterson; P A Scherle; W Gerhard; A J Caton
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity.

Authors:  M S Horwitz; Y Yanagi; M B Oldstone
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

4.  Derivation of T-cell receptor alpha-chain double expresser lines from normal murine mature T cells.

Authors:  K Eshima; H Suzuki; S Yamazaki; N Shinohara
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

5.  The expression of mouse T-cell receptor TCRDV genes in BALB/c spleen.

Authors:  K Wang; C L Kuo; B F Koop; L Hood
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Haplotypic origin of beta-chain genes expressed by human T-cell clones.

Authors:  E Seboun; N Joshi; S L Hauser
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 7.  Mouse T-cell receptor variable gene segment families.

Authors:  B Arden; S P Clark; D Kabelitz; T W Mak
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 8.  Analysis of the immune system with transgenic mice: T cell development.

Authors:  H Bluethmann
Journal:  Experientia       Date:  1991-09-15

9.  Horse (Equus caballus) T-cell receptor alpha, gamma, and delta chain genes: nucleotide sequences and tissue-specific gene expression.

Authors:  M D Schrenzel; D A Ferrick
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Diversity of T-cell receptor alpha gene transcripts in the newborn and adult periphery.

Authors:  S D Thompson; M Larché; A R Manzo; J L Hurwitz
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.